Back to results
US 2025/0026826 A1Published application
Anti-lair1 antibodies for the treatment of cancer
AssigneeUniversity of Florida Research Foundation, Inc.
InventorJianping Huang
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a method of treating cancer, comprising administering an anti-LAIR1 antibody to a subject suffering from a cancer that is resistant to checkpoint inhibitor blockade therapy.
Claims10
A method of treating cancer, comprising administering an anti-LAIR1 antibody to a subject suffering from a cancer that is resistant to checkpoint inhibitor therapy.
The method of any one of claims 1-4, wherein the cancer is glioblastoma.
The method of any one of claims 1-5, wherein the antibody is a humanized antibody.
Dependencies are inferred from the claim text.